ketamine  - Drug Details
📊 Estimates ketamine  Dialyzability By Different_Modalities

ketamine 

Complete Drug Information

Drug Name
ketamine 
Trade Names
Ketalar
Pregnancy Category
AU: B3
Bioavailability
Intravenous: 100% Intramuscular: 93% Epidural: 77% Intranasal: 45–50% Sublingual: 24–30% Rectal: 25–30% By mouth: 16–20%
Routes of Administration
Any
Protein Binding
23–47%%
Metabolism
Liver, intestine (oral): Major: CYP3A4, CYP2B6
Elimination
Ketamine: 2.5–3 hours Norketamine: 12 hours
Excretion
Urine: 91% Feces: 3%
Formula
C13H16ClNO
Molar Mass
237.73
Onset of Action
1–5 min
Duration of Action
0.5–2 h
Melting Point
92 °C
Drug Class
NMDA receptor antagonist; general anesthetic; dissociative hallucinogen; analgesic; antidepressant
Volume of Distribution
4 L/kg

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.